← Back to Screener
Zimmer Biomet Holdings, Inc. (ZBH)
Price$82.94
Value ScoreB
Growth ScoreC
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-23.50%
Price vs S&P 500 (4W)-5.66%
VGM Score54.83
Market Capitalization$15.93B
P/E Ratio (Annual)22.59x
Indicated Dividend Yield (Annual)1.04%
All Metrics
P/CF (Annual)9.39x
Book Value / Share (Quarterly)$65.53
P/TBV (Annual)2.23x
Indicated Dividend (Annual)$0.96
Revenue Growth (3Y)5.85%
Cash Flow / Share (Quarterly)$5.43
Payout Ratio (TTM)24.89%
Price vs S&P 500 (YTD)-19.37%
Gross Margin (TTM)70.03%
Net Profit Margin (TTM)9.05%
EPS (TTM)$3.85
10-Day Avg Trading Volume2.33M
EPS Excl Extra (TTM)$3.85
Revenue Growth (5Y)3.22%
EPS (Annual)$3.55
Dividend / Share (Annual)$0.96
ROI (Annual)3.49%
Gross Margin (Annual)69.71%
Net Profit Margin (5Y Avg)8.68%
Cash / Share (Quarterly)$2.19
P/E Basic Excl Extra (TTM)20.94x
Revenue Growth QoQ (YoY)9.30%
P/E Normalized (Annual)22.59x
ROA (Last FY)3.05%
Revenue Growth TTM (YoY)9.23%
EBITD / Share (TTM)$9.39
ROE (5Y Avg)5.22%
Operating Margin (TTM)14.02%
Cash Flow / Share (Annual)$5.73
P/B Ratio1.26x
P/B Ratio (Quarterly)1.38x
Net Income / Employee (Annual)$41,500
EV / Revenue (TTM)2.73x
Net Interest Coverage (TTM)3.84x
ROA (TTM)3.30%
EPS Growth QoQ (YoY)33.49%
EV / EBITDA (TTM)12.38x
EPS Incl Extra (Annual)$3.55
Current Ratio (Annual)1.98x
Quick Ratio (Quarterly)0.75x
3-Month Avg Trading Volume2.30M
52-Week Price Return-11.80%
EV / Free Cash Flow (Annual)20.52x
P/E Incl Extra (TTM)20.94x
Revenue / Employee (TTM)$494,700
Tangible BV / Share (Quarterly)$42.02
P/S Ratio (Annual)1.94x
Asset Turnover (Annual)0.36x
52-Week High$108.29
Operating Margin (5Y Avg)13.51%
EPS Excl Extra (Annual)$3.55
CapEx CAGR (5Y)7.11%
Tangible BV CAGR (5Y)9.21%
26-Week Price Return-7.57%
Quick Ratio (Annual)0.89x
13-Week Price Return-18.48%
Total Debt / Equity (Annual)0.59x
Current Ratio (Quarterly)1.73x
Enterprise Value$22.97B
Revenue / Share Growth (5Y)4.07%
Asset Turnover (TTM)0.36x
Book Value / Share Growth (5Y)2.07%
Revenue / Employee (Annual)$484,200
Inventory Turnover (Annual)1.10x
Pretax Margin (Annual)10.09%
Cash / Share (Annual)$3.03
3-Month Return Std Dev32.80%
Gross Margin (5Y Avg)71.04%
Net Income / Employee (TTM)$44,800
EBITDA CAGR (5Y)28.18%
EBITDA Interim CAGR (5Y)4.92%
ROE (Last FY)5.55%
Net Interest Coverage (Annual)4.06x
EPS Basic Excl Extra (Annual)$3.55
P/FCF (TTM)15.16x
Receivables Turnover (TTM)5.16x
EV / Free Cash Flow (TTM)21.87x
Total Debt / Equity (Quarterly)0.59x
EPS Incl Extra (TTM)$3.85
Receivables Turnover (Annual)5.17x
ROI (TTM)3.74%
Dividend Growth Rate (5Y)0.12%
P/S Ratio (TTM)1.89x
Pretax Margin (5Y Avg)10.23%
Revenue / Share (Annual)$41.43
Tangible BV / Share (Annual)$40.82
Forward P/E9.47x
Free OCF CAGR (5Y)7.09%
Price vs S&P 500 (52W)-40.00%
P/E Ratio (TTM)20.94x
EPS Growth TTM (YoY)-14.64%
Year-to-Date Return-8.44%
5-Day Price Return-3.71%
EPS Normalized (Annual)$3.55
ROA (5Y Avg)2.97%
Net Profit Margin (Annual)8.57%
Month-to-Date Return-0.12%
Cash Flow / Share (TTM)$6.73
EBITD / Share (Annual)$8.88
EPS Growth (3Y)47.75%
Operating Margin (Annual)13.34%
LT Debt / Equity (Annual)0.55x
P/CF (TTM)9.52x
ROI (5Y Avg)3.46%
P/E Excl Extra (TTM)20.94x
LT Debt / Equity (Quarterly)0.50x
EPS Basic Excl Extra (TTM)$3.85
P/TBV (Quarterly)2.15x
Payout Ratio (Annual)26.99%
P/B Ratio (Annual)1.40x
Dividend / Share (TTM)$0.97
Inventory Turnover (TTM)1.12x
Pretax Margin (TTM)10.74%
Book Value / Share (Annual)$64.95
Price vs S&P 500 (13W)-28.22%
Dividend Yield (TTM)1.19%
Beta0.48x
P/FCF (Annual)14.22x
Revenue / Share (TTM)$42.95
ROE (TTM)6.01%
52-Week Low$79.12
vGradeB
gGradeC
mGradeD
vgmGradeC
Show chart for
Earnings Surprise History
Q1 262.09est. 1.88
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.38
3.37
3.32
3.31
Industry Peers — Orthopedic & Prosthetic Devices(33)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ZBHZimmer Biomet Holdings, Inc. | B | C | D | $82.94 |
| ISRGIntuitive Surgical Inc. | D | B | D | $412.26 |
| EWEdwards Lifesciences Corp | D | C | C | $88.16 |
| STESTERIS plc | C | B | D | $211.07 |
| ALGNAlign Technology Inc | C | C | C | $169.77 |
| SNNSmith & Nephew plc | B | C | C | $29.48 |
| MSAMine Safety Incorporated | C | C | C | $163.13 |
| ESTAEstablishment Labs Holdings Inc. | F | A | B | $68.08 |
| CDRECadre Holdings, Inc. | C | C | D | $30.62 |
| ENOVEnovis Corporation | B | D | D | $21.70 |
| AVNSAvanos Medical, Inc. | B | D | A | $25.05 |
About
Zimmer Biomet is a leading designer and manufacturer of orthopedic reconstructive implants and surgical equipment, with dominant market positions in the United States, Europe, and Japan. The company derives approximately two-thirds of revenue from large joint reconstructions, with the remainder from trauma, sports medicine, and extremities products. In 2022, Zimmer spun out its dental and spine businesses to focus on orthopedic reconstruction.